CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 60 enrolled
Drug / intervention
Placebo +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01634256
NCT01634256Phase 3Completed
CompareCT.gov

A Human Trial to Evaluate the Efficacy and Safety of Fermented Turmeric in Subjects Showing Mild Hepatic Injury

Chonbuk National University Hospital·interventional·Posted Jul 6, 2012·Updated Oct 4, 2012

In Brief

A Phase 3 clinical trial evaluating Placebo and Fermented turmeric for Mild Hepatic Injury. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The investigators performed a double-blind parallel study in a group of showing mild hepatic injury subjects who were given Fermented turmeric over a period of 12 weeks. The investigators measured liver function parameters , including ALT(Alanine Transaminase), AST(Aspartate Transaminase), ALP(Alkaline Phosphatase), γ-GT(Gamma-Glutamyl Transferase), and serum bilirubin, and monitored their blood pressure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMild Hepatic Injury
CountriesSouth Korea
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 6, 2012
Enrollment StartFeb 1, 2011
Primary CompletionOct 1, 2011
Study CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 14.0 years ago

Interventions

Placebodietary

Placebo(3.0g/day)

Fermented turmericdietary

Fermented turmeric(3.0g/day)